Hong Kong Stock Movement | InnoCare Pharma-B (07630.HK) rises over 3% as it expects mid-term losses to decrease by approximately 22% to 37% year-on-year and has nominated IMP2794 as PPC.

According to Zhitong Finance APP, Inpact Pharmaceuticals-B (07630.HK) has risen over 3%. As of the time of writing, it is up 2.64%, trading at HKD 12.43, with a transaction volume of HKD 3.0636 million.